WebSep 11, 2011 · @jeff_cranmer · Mar 2. Why the most important change in EU pharma law in decades in shaping up to be a missed opportunity to reverse a long slide in the region’s competitiveness. ... BioCentury's webinar will discuss how new US legislation will influence orphan drug development strategies. pipeline prioritization, portfolio investment ... WebJeff Cranmer Bayer AG Vividion Therapeutics Inc. EQRx Inc. Moderna Inc. Translate Bio Inc. AstraZeneca... Read More BioCentury Aug 3, 2024 Deals A $3.2B takeout of partner Translate Bio tees Sanofi up to build out mRNA franchise ...widened, Sanofi has proposed to acquire partner Translate Bio ...
The BioCentury Show - Team
WebApr 28, 2024 · Jeff Cranmer BeiGene Ltd. I-Mab Biopharma GenScript... Read More BioCentury Jul 31, 2024 Finance What’s next for China’s biopharmas after a roller-coaster week ...will likely begin contingency planning, as I-Mab Biopharma (NASDAQ: IMAB ... Read More BioCentury Jul 29, 2024 Finance WebApr 28, 2024 · For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, … c in fancy letter
Translate Bio Inc. - Company Profiles - BCIQ
WebJun 21, 2012 · Jeff Cranmer @jeff_cranmer · Oct 20, 2024 CRISPR innovation hits the gas: A publication streak in #CRISPR gene editing is building momentum for methods that can break the barriers to the technology's use in drug development. via @BioCentury 's @DanielleGolovin : biocentury.com CRISPR innovation hits the gas WebBioCentury Jan 7, 2024 Management Tracks Alkermes promotes two to oversee growth plan as CFO Frates departs ...By Jeff Cranmer, Executive Editor As James Frates prepares to depart Alkermes after two decades, the... ...unveiled in December in the wake of discussions with activist investor Elliott Advisors.Frates, who joined Alkermes plc ... WebBioCentury's Analysts & Research Team is comprised of industry-recognized business and science editors, writers and analysts, delivering trusted intelligence 24/7. ... Vice … BioCentury was founded 30 years ago by Karen Bernstein and David Flores to … c. infection